JW Therapeutics is a biopharmaceutical company that develops and commercializes cell-based immunotherapies for the treatment of cancer. Read more

5 Followers on Owler
5 Followers on Owler
5 Followers on Owler
5 Followers on Owler

JW Therapeutics is a biopharmaceutical company that develops and commercializes cell-based immunotherapies for the treatment of cancer. Read more

James Li's photo - Co-Founder & CEO of JW Therapeutics

Co-Founder & CEO

James Li

CEO Approval Rating

85/100

Founded:

2016

Status:

PublicIndependent CompanyHong Kong Stock Exchange02126

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Kite Pharma is the biggest rival of JW Therapeutics. Kite Pharma was founded in 2009, and its headquarters is in Santa Monica, California. Kite Pharma operates in the Biotechnology industry. Kite Pharma has 2,000 more employees than JW Therapeutics.

bluebird bio has been one of JW Therapeutics's top competitors. bluebird bio is a Public company that was founded in Cambridge, Massachusetts in 1992. bluebird bio is in the Biotechnology industry. bluebird bio has 1,171 more employees vs. JW Therapeutics.

NexImmune is JW Therapeutics's #3 rival. NexImmune was founded in 2011 in Gaithersburg, Maryland. NexImmune is in the Biotechnology field. NexImmune generates $22M more revenue than JW Therapeutics.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is NantKwest a competitor of JW Therapeutics?

Quarterly and Annual Revenue

Coming soon for JW Therapeutics!

Annual Revenue

Acquisitions

No recent acquisitions found related to JW Therapeutics

JW Therapeutics Funding History

$90M$490M

Since JW Therapeutics was founded in 2016, it has participated in 3 rounds of funding. In total JW Therapeutics has raised $490.0M. JW Therapeutics' last funding round was on Nov 2020 for a total of $300.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Nov 2020
$300M

Series B
Jun 2020
$100M
Series A
Mar 2018
$90M

Since JW Therapeutics was founded in 2016, it has participated in 3 rounds of funding. In total JW Therapeutics has raised $490.0M. JW Therapeutics' last funding round was on Nov 2020 for a total of $300.0M

Investments

No recent investments found related to JW Therapeutics

JW Therapeutics News

November 6, 2020ChinaPulse

JW Therapeutics floats $300m Hong Kong IPO, targets China's first CAR-T approval

Chinese cell therapy developer JW Therapeutics has raised HK$2.325 billion (nearly $300 million) in a... See more »
November 5, 2020BioPharma-Reporter

Chinese cell therapy player generates $300m in IPO

China based CAR-T biotech, JW Therapeutics, has raised $300m in its IPO on the Hong Kong Stock Exchan... See more »
November 4, 2020Endpoints News

JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China

Close to two years after Juno Therapeutics disappeared from Nasdaq, a CAR-T biotech it spawned is set... See more »
November 3, 2020BioSpace

Leading Cell Therapy Company JW Therapeutics Lists on Main Board of HKEX

JW Therapeutics, a leading clinical stage cell therapy company in China that focuses on developing, m... See more »
November 3, 2020Equal Ocean

JW Therapeutics Goes to Public on Hong Kong Stock Exchange

As WuXi AppTech's big-molecular business arm, JW Therapeutics has achieved a milestone amid the secon... See more »
November 3, 2020Hong Kong Exchanges and Clearing Limited

Hong Kong Exchanges and Clearing Limited Welcomes JW Therapeutics

Hong Kong Exchanges and Clearing Limited Welcomes JW Therapeutics... See more »
October 20, 2020ChinaPulse

JW Therapeutics pre-markets Hong Kong IPO

JW (Cayman) Therapeutics has launched pre-deal investor education for its Hong Kong IPO, setting the ... See more »

Social Media

Headquarters

No.4560 Jinke Road, Zhangjiang, Pudong New Area 2F, Bldg.3, Jinchuang Tower

Shanghai, Shanghai Municipality200131

86-21-50464201

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

JW Therapeutics is a biopharmaceutical company that develops and commercializes cell-based immunotherapies for the treatment of cancer. JW Therapeutics was founded in 2016. JW Therapeutics' headquarters is located in Shanghai, Shanghai Municipality, C...

CEO

JW Therapeutics's Co-Founder & CEO, James Li, currently has an approval rating of 85%. JW Therapeutics's primary competitors are Kite Pharma, bluebird bio & NexImmune.

Website

jwtherapeutics.com

Frequently Asked Questions about JW Therapeutics

  1. When was JW Therapeutics founded?

    JW Therapeutics was founded in 2016
  2. Who is JW Therapeutics's CEO?

    JW Therapeutics's CEO is James Li
  3. How much revenue does JW Therapeutics generate?

    JW Therapeutics generates $ < 1M in revenue
  4. How much funding does JW Therapeutics have?

    JW Therapeutics has historically raised $490M in funding
  1. Where is JW Therapeutics's headquarters?

    JW Therapeutics's headquarters is in Shanghai Shanghai Municipality, CN
  2. How many employees does JW Therapeutics have?

    JW Therapeutics has 0 employees
  3. What sector does JW Therapeutics operate in?

    JW Therapeutics is in Pharmaceuticals, Biotechnology
  4. Who are JW Therapeutics's competitors?

    JW Therapeutics's top competitors are Kite Pharma, bluebird bio, NexImmune